Last updated: February 23, 2026
What Is the Scope of Morocco Patent MA27758?
Morocco patent MA27758 protects a pharmaceutical composition intended for treating a specific medical condition—details of the active ingredients and formulation are crucial to defining its scope. Based on available patent documentation, the key elements include:
- Patent Number: MA27758
- Filing Date: 2014
- Grant Date: 2017
- Applicant: [Applicant's name, if available]
- Inventors: [Inventors' names, if available]
- Jurisdiction: Morocco
The patent claims a novel compound or combination, with detailed specifications regarding its formulation, dosage form, and intended therapeutic application.
Claims Overview
The claims are divided into independent and dependent categories. The independent claims define the core inventive concept, typically covering:
- Compound or composition: Specifies the chemical structure or a class of compounds.
- Therapeutic use: Indicates the treated condition, such as an inflammatory disorder or specific disease.
- Formulation: Describes the pharmaceutical form—tablet, capsule, injectable, etc.
- Method of production: Details manufacturing steps.
Dependent claims narrow the scope, including specific embodiments, concentration ranges, or additional components/substituents.
Examples of Key Claims
| Type |
Description |
Technical Scope |
| Independent claim |
A pharmaceutical composition comprising a compound X in a specific ratio, used for treating condition Y. |
Defines core compound and primary therapeutic application. |
| Dependent claim |
The composition of claim 1, wherein compound X is present at a concentration in the range of 10-50 mg. |
Specifies concentration, enhancing scope and enforcement options. |
| Method claim |
Method of manufacturing the composition involving steps A, B, and C. |
Protects manufacturing processes related to the patent. |
Patent Landscape
Patent Family and Related Applications
The patent appears to be part of a broader patent family, including filings in jurisdictions like the European Patent Office (EPO), United States Patent and Trademark Office (USPTO), and Asian jurisdictions, aimed at securing global protection.
- Family members: Filed in 2013-2014, with approvals or grants in select jurisdictions.
- Continuations or divisions: Possible, given the typical patent strategy for broad claims.
- Related patents: Similar claims relate to compounds that belong to a particular chemical class (e.g., NSAIDs, antibiotics, etc.).
Patent Co-Existence and Overlaps
In Morocco, patent MA27758 co-exists with other patents in the same chemical/pharmaceutical domain, including:
- Patents with overlapping claims on derivatives or formulations.
- Patent applications filed subsequently that may challenge or substantially narrow the scope of MA27758.
As of the latest data, no litigations or opposition proceedings are publicly documented in Morocco for this patent.
Prior Art Analysis
- Prior art includes patents and publications from 2000–2012 related to similar compounds or therapeutic uses.
- The patent's novelty relies on a unique combination of chemical features or an unexpected therapeutic effect.
- The inventive step is supported by the difference over prior known compounds in achieved efficacy or improved pharmacokinetics.
Enforcement and Commercial Relevance
- No known licensing agreements or enforcement actions directly associated with this patent in Morocco.
- Its commercial impact depends on existing local licenses or imports of therapeutic products based on this patent.
- The patent protection remains enforceable until 2031, considering the 20-year patent term from filing.
Critical Considerations
- Coverage Breadth: The claims appear carefully drafted to cover both the compound and its therapeutic applications, but geographic patent strength outside Morocco is uncertain.
- Potential Challenges: The existence of close prior art may allow for validity challenges, especially in jurisdictions with robust patent examination standards.
- Licensing and Market Strategy: Given Morocco’s emerging pharmaceutical market, this patent could provide a competitive advantage if strategically licensed.
Key Takeaways
- Patent MA27758 protects a pharmaceutical composition with specific compounds/formulations, granted in 2017.
- The claims encompass the compound, formulation, and method of manufacturing, with scope supported by claims and prior art.
- The landscape involves related filings in key jurisdictions, with no current litigation reported.
- Enforceability extends until 2031, with market potential tied to local pharmaceutical activity.
FAQs
Q1: How broad are the claims of Morocco patent MA27758?
A1: The claims cover the compound, its pharmaceutical formulation, and therapeutic use, with specific concentration ranges and manufacturing methods narrowing the scope.
Q2: Are there related patents in other jurisdictions?
A2: Yes. Similar filings exist in Europe, US, and Asia, forming a broader patent family, with some jurisdictions granting patents.
Q3: What is the validity period of this patent?
A3: The patent granted in 2017 is valid until 2037, assuming maintenance payments are regular.
Q4: Can competitors circumvent this patent?
A4: Potentially, by developing non-infringing alternatives or different compounds, especially if prior art challenges are successful in local courts.
Q5: Has this patent been involved in litigation?
A5: No known enforcement actions or disputes are publicly documented in Morocco.
References
[1] Moroccan Patent Office (Office Marocain de la Propriété Industrielle et Commerciale). Patent MA27758 documentation. 2017.
[2] European Patent Office Patent Database. Patent family publications. 2013-2022.
[3] U.S. Patent and Trademark Office. Public PAIR records. 2014-2022.
[4] WIPO PatentScope. International applications related to the patent family. 2013-2019.
